Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa.
- A. Chow, V. Chow, K. Packo, J. Pollack, G. Peyman, R. Schuchard
- Medicine
- Archives of ophthalmology
- 1 April 2004
OBJECTIVE
To determine the safety and efficacy of the artificial silicon retina (ASR) microchip implanted in the subretinal space to treat vision loss from retinitis pigmentosa.
METHODS
The ASR… Expand
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.
Uveal melanoma (UM) is the most common cancer in adult eyes. Approximately 80% of UMs harbor somatic activating mutations in GNAQ or GNA11 (encoding Gq or G11, respectively). Herein, we show in both… Expand
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
- M. Soheilian, A. Ramezani, +8 authors G. Peyman
- Medicine
- Ophthalmology
- 1 June 2009
PURPOSE
To compare the results of intravitreal bevacizumab (IVB) injection alone or in combination with intravitreal triamcinolone acetonide (IVT) versus macular laser photocoagulation (MPC) as a… Expand
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
- Roberta P A Manzano, G. Peyman, +5 authors P. Chévez-Barrios
- Medicine
- British Journal of Ophthalmology
- 19 December 2006
Aim: To evaluate the effect of topically administered bevacizumab (Avastin) on experimental corneal neovascularisation in rats. Methods: Silver nitrate sticks (75% silver nitrate, 25% potassium… Expand
Micro- and nanoparticulates.
- A. Moshfeghi, G. Peyman
- Medicine
- Advanced drug delivery reviews
- 13 December 2005
OBJECTIVES
Pharmacotherapeutics has begun to play an increasingly important role in the management of patients with neovascular age-related macular degeneration (AMD). Because micro- and… Expand
A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring.
- G. Peyman, K. J. Blinder, C. L. Paris, W. Alturki, N. Nelson, U. Desai
- Medicine
- Ophthalmic surgery
- 1 February 1991
We describe the surgical excision of submacular scar in end-stage age-related macular degeneration and transplantation of autologous and homologous retinal pigment epithelial (RPE) cells. The… Expand
TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)
- Roberta P A Manzano, G. Peyman, P. Khan, M. Kivilcim
- Medicine
- Retina
- 1 March 2006
Purpose: To evaluate the retinal toxicity of varying doses of bevacizumab when injected intravitreally in rabbits. Bevacizumab has been approved by the US Food and Drug Administration for the… Expand
Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema
- M. Conway, C. Canakis, C. Livir-Rallatos, G. Peyman
- Medicine
- Journal of cataract and refractive surgery
- 1 January 2003
Purpose: To determine the safety and efficacy of intravitreal triamcinolone acetonide (TAAC) injections in patients with refractory cystoid macular edema (CME) after cataract extraction. Setting: LSU… Expand
Triamcinolone acetonide in ocular therapeutics.
- C. Jermak, J. Dellacroce, J. Heffez, G. Peyman
- Medicine
- Survey of ophthalmology
- 1 September 2007
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. Its use has increased dramatically in recent years for periocular and intraocular treatment of retinal… Expand